Clinical Trial Update: Safety and Efficacy of Sofosbuvir + Velpatasvir With or Without Ribavirin in Treatment-Naive Adults With Chronic HCV Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sofobuvir/velpatasvir with or without ribavirin in treatment-naive chronic hepatitis C patients completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sofosbuvir/Velpatasvir (sofosbuvir/velpatasvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2016-09-15